Chartwell Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CHARTWELL PHARMA, and what generic and branded alternatives to CHARTWELL PHARMA drugs are available?
CHARTWELL PHARMA has one approved drug.
Drugs and US Patents for Chartwell Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chartwell Pharma | LYMEPAK | doxycycline hyclate | TABLET;ORAL | 209844-001 | Jun 15, 2018 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.